CSIMarket
 
Global Cord Blood Corp  (NYSE: CO)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 122
 Employees 1,561
 Revenues (TTM) (Millions $) 196
 Net Income (TTM) (Millions $) 80
 Cash Flow (TTM) (Millions $) 92
 Capital Exp. (TTM) (Millions $) 3

Business Description


Global Cord Blood Corp.
is a company specialized in the collection, processing, and storage of umbilical cord blood stem cells.
These cells are obtained from the umbilical cord of newborn babies and used in treating various diseases, such as leukemia, sickle cell anemia, and other blood-related disorders.
The company was founded in 2008 and is headquartered in Hong Kong, with operations in China and other countries.
The company operates two main segments: cord blood storage services and hematopoietic stem cell transplantation services.
The cord blood storage services segment includes the collection, testing, processing, and storage of cord blood stem cells for future use.
The hematopoietic stem cell transplantation services segment involves providing cord blood stem cells for transplantation and coordinating the use of these cells for patients in need.
Global Cord Blood Corp has developed a strong reputation for quality and innovation in the cord blood banking industry.
The company maintains strict standards for the processing and storage of cord blood stem cells, and has earned accreditation from various international regulatory bodies.
The company is committed to providing affordable, high-quality cord blood banking services to families across the globe.
As of March 31, 2021, Global Cord Blood Corp had stored approximately 952,000 samples of cord blood from newborns.
The company's customer base includes individuals, families, and medical institutions.
Additionally, Global Cord Blood Corp has established partnerships with hospitals and research institutions to advance the use of cord blood stem cells in treatments for various diseases.
The company is publicly traded on the New York Stock Exchange under the symbol CO.
Global Cord Blood Corp is led by a team of experienced executives who are committed to the success of the company and its customers.
With its advanced technology, strict quality standards, and commitment to innovation, Global Cord Blood Corp is poised to remain a prominent player in the cord blood banking industry for years to come.


   Company Address: 48th Floor, Bank of China Tower Central 0
   Company Phone Number: 3605 8180   Stock Exchange / Ticker: NYSE CO


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Announcement

Legal Advisory for Global Cord Blood Corporation Investors by Renowned Rosen Law Firm with June 24 Deadline for Secur...

Published Sun, Jun 16 2024 8:47 PM UTC

Rosen Law Firm Urges Global Cord Blood Corporation Investors to Seek Counsel Before Crucial June 24 Deadline in Securities Class Action NEW YORK, June 16, 2024 Rosen Law Firm, a preeminent global investor rights legal practice, has issued an advisory urging investors in the securities of Global Cord Blood Corporation (NYSE: CO, OTC: CORBF) to secure legal representation ...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 9.7
Working Capital Ratio 10.05
Leverage Ratio (MRQ) 0.8
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0.65 $
Revenues (TTM) 1.61 $
Cash Flow (TTM) 0.76 $
Cash 7.63 $
Book Value 5.51 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 125,637
Net Income per Employee (TTM) 51,486
Receivable Turnover Ratio (TTM) 7.09
Inventory Turnover Ratio (TTM) 4.53
Asset Turnover Ratio (TTM) 0.16

Profitability Ratios Current
Gross Margin (MRQ) 85.26 %
Operating Margin (MRQ) 48.97 %
Net Margin (MRQ) 40.98 %
Net Cash Flow Margin (MRQ) 46.88 %
Effective Tax Rate (TTM) 18.85 %

Management Effectiveness Current
Return On Assets (TTM) 6.58 %
Return On Investment (TTM) 7.14 %
Return On Equity (TTM) 11.78 %
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.